Chemotherapy resistance of mouse WAP-SVT/t breast cancer cells is mediated by osteopontin, inhibiting apoptosis downstream of caspase-3
Open Access
- 11 December 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 26 (20), 2840-2850
- https://doi.org/10.1038/sj.onc.1210096
Abstract
Impairment of the complex regulatory network of cell death and survival is frequently the reason for therapy resistance of breast cancer cells and a major cause of tumor progression. We established two independent cell lines from a fast growing mouse breast tumor (WAP-SVT/t transgenic animal). Cells from one line (ME-A cells) are sensitive to apoptotic stimuli such as growth factor depletion or treatment with antitumor agents (e.g. doxorubicin). Cells from the second line (ME-C cells), which carry a missense mutation at the p53 codon 242, are very insensitive to apoptotic stimuli. Co-cultivation experiments revealed that the ME-C cells mediate cell death resistance to the ME-A cells. Microarray and Western blot analysis showed that osteopontin (OPN) is selectively overexpressed by the ME-C cells. This glycoprotein is the most abundant protein secreted by the ME-C cells and we obtained strong indications that OPN is the main antiapoptotic factor. However, the OPN containing ME-C cell medium does not alter the expression level of pro- or antiapoptotic genes or known inhibitors of apoptosis (IAPs). Its signaling involves mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) kinase (MEK)1/2 as the kinase inhibitor PD98059 restores apoptosis but not the Akt inhibitor. In the ME-A cells, mitochondrial cytochrome c release occurs with and without external apoptotic stimuli. OPN containing ME-C cell medium does not prevent the mitochondrial cytochrome c release and caspase-9 processing. In serum starved ME-A cells, the OPN containing ME-C cell medium prevents caspase-3 activation. However, in doxorubicin-treated cells, although apoptosis is blocked, it does not inhibit caspase-3. This indicates that the ME-A cells distinguish between the initial apoptotic stimuli and that the cells possess a further uncharacterized control element acting downstream from caspase-3.Keywords
This publication has 43 references indexed in Scilit:
- Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implicationsBiochemical Journal, 2005
- Oxidants Inhibit ERK/MAPK and Prevent Its Ability to Delay Neutrophil Apoptosis Downstream of Mitochondrial Changes and at the Level of XIAPPublished by Elsevier BV ,2004
- `The stress of dying': the role of heat shock proteins in the regulation of apoptosisJournal of Cell Science, 2004
- Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPKNature, 2003
- Pre-processed caspase-9 contained in mitochondria participates in apoptosisCell Death & Differentiation, 2002
- The Functional and Clinical Roles of Osteopontin in Cancer and MetastasisCurrent Molecular Medicine, 2001
- Akt Phosphorylation Site Found in Human Caspase-9 Is Absent in Mouse Caspase-9Biochemical and Biophysical Research Communications, 1999
- Death Receptors: Signaling and ModulationScience, 1998
- Mitochondria and ApoptosisScience, 1998
- A Biochemical Characterization of the Binding of Osteopontin to Integrins αvβ1 and αvβ5Journal of Biological Chemistry, 1995